Zien Medical Technologies
Private Company
Funding information not available
Overview
Zien Medical Technologies, founded in 2018 and headquartered in San Francisco, operates as a full-service partner for medical device development and manufacturing. The company's core value proposition is providing an integrated, capital-efficient path to market for startups and entrepreneurs, leveraging its ISO 13485-certified infrastructure and regulatory expertise to reduce typical development timelines by 12-24 months and costs by up to 70%. By managing design control, manufacturing, packaging, sterilization, and global regulatory compliance, Zien enables its clients to focus on commercialization while it handles the complexities of bringing a physical device to market. It serves a broad range of surgical and interventional specialties, positioning itself as a critical enabler in the digital health and medical device ecosystem.
Technology Platform
Integrated service platform for medical device development and manufacturing, centered on an ISO 13485-certified Quality Management System. Includes capabilities in design control, regulatory strategy, laser cutting, Nitinol processing, process validation, contract packaging, sterilization, and provision of digital Instructions for Use (EIFUs).
Opportunities
Risk Factors
Competitive Landscape
Zien competes in the medical device contract development and manufacturing organization (CDMO) space. Competitors range from large, global public CDMOs (e.g., Integer, Flex, Jabil) to smaller, specialized engineering and manufacturing shops. Zien's differentiation is its integrated, full-service model targeted specifically at startups, offering both strategic regulatory guidance as Manufacturer of Record and hands-on manufacturing execution.